MedPath

Improving Performance in Drivers With Mild Cognitive Impairment

Not Applicable
Completed
Conditions
Mild Cognitive Impairment
Interventions
Behavioral: Brain Health Workshop
Behavioral: Goal Management Training
Behavioral: Processing Speed Training
Registration Number
NCT01935219
Lead Sponsor
Baycrest
Brief Summary

The objective of this study is to assess the effectiveness of an intervention to address both executive function and processing speed changes that contribute to poor driving performance in adults with Mild Cognitive Impairment (MCI).

Our hypotheses are that the study intervention will improve performance on a driving simulator and will improve (i) executive function, specifically attention and planning, (ii) useful field of view, (iii) mood, (iv) quality of life, and (v) reported motor vehicle crashes and driving infractions.

Detailed Description

Executive function and processing speed are recognized critical correlates of driving performance and have been shown to decline in older adults and in persons with mild cognitive impairment. Members of our research team have shown that group executive function training such as Goal Management Training results in benefits for healthy older adults, including improved simulated daily activities. The ultimate purpose of our research is to develop interventions to help maintain older adults' mobility in order to assist their 'aging at home'. The planned study will assess the effectiveness of an intervention that includes Goal Management Training + processing speed training (using DriveSharp software), which is designed to address both executive function and processing speed changes that contribute to poor driving performance in people with diagnosed mild cognitive impairment. The investigators will measure the effectiveness of the intervention on driving performance, sustained attention, divided attention, executive function, depressive symptoms and quality of life.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • mild cognitive impairment
  • currently driving or voluntarily stopped driving within the past year
  • fluent in English
Exclusion Criteria
  • visual problems that cannot be corrected with standard lenses
  • alcohol/substance abuse
  • stroke with residual motor /sensory deficit
  • traumatic brain injury
  • seizure in the past two years
  • Parkinson's disease
  • Multiple sclerosis
  • untreated sleep apnea
  • history of motion sickness
  • history of dizziness, vertigo
  • active primary psychiatric disorder requiring treatment
  • on a dose of cognitive enhancing medication for less than 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Brain Health Workshop + computer assignmentsBrain Health WorkshopGroup participates in Brain Health Workshop and is provided with computer assignments to match for time spent on the computer in the other arms.
Goal Management Training + Processing Speed TrainingGoal Management TrainingGroup receives both Goal Management Training and as well as Processing Speed Training using DriveSharp software.
Goal Management Training + Processing Speed TrainingProcessing Speed TrainingGroup receives both Goal Management Training and as well as Processing Speed Training using DriveSharp software.
Processing Speed Training + Brain Health WorkshopBrain Health WorkshopGroup receives both Processing Speed Training (using DriveSharp) and participates in a Brain Health Workshop that is matched to Goal Management Training for session length and contact with trainer.
Processing Speed Training + Brain Health WorkshopProcessing Speed TrainingGroup receives both Processing Speed Training (using DriveSharp) and participates in a Brain Health Workshop that is matched to Goal Management Training for session length and contact with trainer.
Primary Outcome Measures
NameTimeMethod
Driving Performance33-38 weeks

Measurements obtained on a computer-based driving simulation

Secondary Outcome Measures
NameTimeMethod
Sustained Attention to Response Task (SART)9-14 weeks, 33-38 weeks

Sustained attention

D-KEFs Tower Test9-14 weeks, 33-38 weeks

Visuospatial planning

Useful Field of View Test (UFOV)9-14 weeks, 33-38 weeks

Visual field of view

Cognitive Failures Questionnaire9-14 weeks, 33-38 weeks

Absentmindedness, executive dysfunction in daily life

Quality of Life: AD (QOL-AD)9-14 weeks, 33-38 weeks

Quality of life with MCI and Alzheimer's disease

Dysexecutive Questionnaire9-14 weeks, 33-38 weeks

Absentmindedness, executive dysfunction in daily life

Geriatric Depression Scale (GDS-15 item)9-14 weeks, 33-38 weeks

Depressive symptoms

Trial Locations

Locations (1)

Baycrest Health Sciences

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath